MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
KNSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kiniksa Pharmaceuticals International (KNSA) Ownership - Who owns Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
105 Piccadilly
Phone
+44 7814319100
Employees
366
Web
https://www.kiniksa.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
5.99B
P/E Ratio
77.53
Total Cash
525.93M
Projected Growth
N/A
Total Debt
8.9M
Revenue
840.85M
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash/Share
6.74
Total Debt/Equity
N/A
Revenue/Share
10.26 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
KNSA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for KNSA
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Major
Address
105 Piccadilly
Phone
+44 7814319100
Employees
366
Web
https://www.kiniksa.com
Who owns Kiniksa Pharmaceuticals International? KNSA symbol Ownership - Tickeron.com